356H Form Instructions - Bsufa, gdufa, mdufma • need for additional tracking (e.g., rare disease information) • need to clarify types of information being submitted and provide clear and concise instructions • need to account for proliferation of electronic submissions (the field numbers below correspond to the numbered boxes on the. Web for form fda 356h, the guidance says that applicants “should include complete information on the locations of all manufacturing, packaging, and control sites for both drug substance and drug product,” among others. Web • the form fda 356h should be used with all submissions to fda regarding a biologics license including supplements for review and approval [21 cfr 601.12(b) and (c)], Web internally at the fda this gfi is commonly referred to as the ‘356h guidance’, as it covers the information required on the fda 356h form when submitting original or supplemental new drug application, abbreviated new drug application, biologics license application or a related amendment. Web why was the form updated? • new user fee programs: However, facilities “that do not impact or inform the commercial control strategy do not need to be listed on form fda 356h.”
Bsufa, gdufa, mdufma • need for additional tracking (e.g., rare disease information) • need to clarify types of information being submitted and provide clear and concise instructions • need to account for proliferation of electronic submissions Web for form fda 356h, the guidance says that applicants “should include complete information on the locations of all manufacturing, packaging, and control sites for both drug substance and drug product,” among others. Web why was the form updated? Web internally at the fda this gfi is commonly referred to as the ‘356h guidance’, as it covers the information required on the fda 356h form when submitting original or supplemental new drug application, abbreviated new drug application, biologics license application or a related amendment. However, facilities “that do not impact or inform the commercial control strategy do not need to be listed on form fda 356h.” (the field numbers below correspond to the numbered boxes on the. • new user fee programs: Web • the form fda 356h should be used with all submissions to fda regarding a biologics license including supplements for review and approval [21 cfr 601.12(b) and (c)],